🔎 Trials Near Me

Utama › Melanoma › Ohio › Columbus

Kajian klinikal Melanoma di Columbus, OH

21 kajian untuk Melanoma sedang mencari peserta di lokasi dalam dan sekitar Columbus (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
  • Ohio State University Comprehensive Cancer Center, Columbus
  • Mount Carmel East Hospital, Columbus
  • The Mark H Zangmeister Center, Columbus
  • dan 8 lagi
Umur 40 hingga 75 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT05334069

A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)

Mengambil pesertaFasa 3
  • The Ohio State University Wexner Medical Center, Columbus
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT06246916

Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.

Mengambil pesertaFasa 3
  • Ohio State University, Columbus
Umur 18 hingga 70 · Semua jantina · Dikemas kini 24 Sep 2026 · NCT05727904

Comparing the Effectiveness of Less Invasive Procedures With the Current Standard of Care for the Treatment of Older Adults With Early-Stage Melanoma

Mengambil pesertaFasa 3
  • Ohio State University Comprehensive Cancer Center, Columbus
Umur 75 ke atas · Semua jantina · Dikemas kini 24 Sep 2026 · NCT07068074

Personalized Cancer Vaccine (PCV) Strategy in Patients With Solid Tumors and Molecular Residual Disease

Mengambil pesertaFasa 1
  • Ohio State University, Columbus
Umur 18 ke atas · Semua jantina · Dikemas kini 21 Sep 2026 · NCT06529822

A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases

Mengambil pesertaFasa 2
  • Ohio State University Comprehensive Cancer Center, Columbus
  • Mount Carmel East Hospital, Columbus
  • Columbus Oncology and Hematology Associates Inc, Columbus
  • dan 15 lagi
Umur 18 ke atas · Semua jantina · Dikemas kini 15 Sep 2026 · NCT04511013

Project: Every Child for Younger Patients With Cancer

Mengambil pesertaKajian pemerhatian
  • Nationwide Children's Hospital, Columbus
  • Ohio State University Comprehensive Cancer Center, Columbus
Sehingga umur 25 · Semua jantina · Dikemas kini 25 Ogo 2026 · NCT02402244

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

Mengambil pesertaFasa 1/2
  • The Ohio State University Comprehensive Cancer Center, Columbus
Umur 18 ke atas · Semua jantina · Dikemas kini 11 Ogo 2026 · NCT05592626

Intralesional Influenza Vaccine for the Treatment of Stage I-IV Melanoma

Mengambil pesertaFasa 1
  • Ohio State University Comprehensive Cancer Center, Columbus
Umur 18 hingga 99 · Semua jantina · Dikemas kini 13 Jul 2026 · NCT04697576

Natural Killer Cell Therapy (UD TGFbetai NK Cells) and Temozolomide for the Treatment of Stage IV Melanoma Metastatic to the Brain

Mengambil pesertaFasa 1/2
  • Ohio State University Comprehensive Cancer Center, Columbus
Umur 18 ke atas · Semua jantina · Dikemas kini 11 Jun 2026 · NCT05588453

ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors

Mengambil pesertaFasa 1/2
  • Ohio State University Wexner Medical Center Gynecologic Oncology at Mill Run, Columbus
Umur 18 ke atas · Semua jantina · Dikemas kini 13 Mei 2026 · NCT03686124

Neoadjuvant Darovasertib in Primary Uveal Melanoma

Mengambil pesertaFasa 3
  • Ohio State Eye and Ear Institute, Columbus
Umur 18 ke atas · Semua jantina · Dikemas kini 6 Mei 2026 · NCT07015190

A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma

Mengambil pesertaFasa 2/3
  • The Ohio State University, Columbus
Semua umur · Semua jantina · Dikemas kini 2 Apr 2026 · NCT06581406

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

Mengambil pesertaKajian pemerhatian
  • Memorial Hospital, Marysville · 27 mi jauh
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Mac 2026 · NCT06418204

EMLA Topical Cream for Treatment of Pain in Patients Receiving Intra-Dermal Technetium 99 Injections for Lymphoscintigraphy for Skin Cancers

Mengambil pesertaFasa 2
  • Ohio State University Comprehensive Cancer Center, Columbus
Umur 18 hingga 99 · Semua jantina · Dikemas kini 10 Mac 2026 · NCT06223659

Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome

Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
  • The Ohio State University Wexner Medical Center, Columbus
Semua umur · Semua jantina · Dikemas kini 9 Mac 2026 · NCT04792463

Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM)

Mengambil pesertaFasa 3
  • The Ohio State University Comprehensive Cancer Center, Columbus
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Feb 2026 · NCT05549297

A Storage Facility for Tissues Obtained From Patients With Malignant Melanoma

Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
  • Ohio State University Comprehensive Cancer Center, Columbus
Semua umur · Semua jantina · Dikemas kini 17 Feb 2026 · NCT04567706

Efficacy of Daromun Neoadjuvant Intratumoral Treatment in Clinical Stage IIIB/C/D Melanoma Patients

Mengambil pesertaFasa 3
  • Ohio State University Wexner Medical Center, Columbus
Umur 18 ke atas · Semua jantina · Dikemas kini 17 Dis 2025 · NCT03567889

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Mengambil pesertaKajian pemerhatian
  • Massive Bio SYNERGY-AI site, Columbus
Semua umur · Semua jantina · Dikemas kini 28 Okt 2025 · NCT03452774

Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma

Mengambil peserta
  • Ohio State University Comprehensive Cancer Center, Columbus
Umur 18 ke atas · Semua jantina · Dikemas kini 27 Nov 2024 · NCT03860883

Kajian Melanoma di bandar lain

Kajian lain di Columbus

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.